Dishman Carbogen Amcis Share Price
Start SIP in Dishman Carbogen Amcis
Start SIPDishman Carbogen Amcis Performance
Day Range
- Low 198
- High 205
52 Week Range
- Low 133
- High 283
- Open Price202
- Previous Close203
- Volume485328
Dishman Carbogen Amcis Investment Rating
-
Master Rating:
-
Dishman Carbogen Amcis has an operating revenue of Rs. 2,416.17 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of -5% needs improvement, ROE of -2% is poor and needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 9% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 103 | 111 | 87 | 60 | 70 | 113 |
| Operating Expenses Qtr Cr | 89 | 100 | 84 | 63 | 75 | 107 |
| Operating Profit Qtr Cr | 15 | 12 | 3 | -3 | -5 | 6 |
| Depreciation Qtr Cr | 16 | 26 | 26 | 25 | 25 | 23 |
| Interest Qtr Cr | 16 | 16 | 17 | 17 | 18 | 17 |
| Tax Qtr Cr | -2 | -3 | -9 | -3 | -12 | -9 |
| Net Profit Qtr Cr | -3 | -31 | -18 | -6 | -21 | -10 |
Dishman Carbogen Amcis Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹197.66
- 50 Day
- ₹191.02
- 100 Day
- ₹190.11
- 200 Day
- ₹186.55
- 20 Day
- ₹199.12
- 50 Day
- ₹185.47
- 100 Day
- ₹185.94
- 200 Day
- ₹195.56
Dishman Carbogen Amcis Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 204.74 |
| Second Resistance | 208.59 |
| Third Resistance | 212.19 |
| RSI | 54.86 |
| MFI | 49.10 |
| MACD Single Line | 4.96 |
| MACD | 4.34 |
| Support | |
|---|---|
| First Support | 197.29 |
| Second Support | 193.69 |
| Third Supoort | 189.84 |
Dishman Carbogen Amcis Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 667,037 | 23,099,491 | 34.63 |
| Week | 891,388 | 31,555,142 | 35.4 |
| 1 Month | 1,248,130 | 44,108,924 | 35.34 |
| 6 Month | 938,117 | 35,592,151 | 37.94 |
Dishman Carbogen Amcis Result Highlights
Dishman Carbogen Amcis Synopsis
NSE-Medical-Diversified
Dishman Carbogen Amc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 402.55 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2023. Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338.| Market Cap | 3,179 |
| Sales | 361 |
| Shares in Float | 6.43 |
| No of funds | 61 |
| Yield |
| Book Value | 0.78 |
| U/D Vol ratio | 1.8 |
| LTDebt / Equity | 4 |
| Alpha | -0.02 |
| Beta | 1.53 |
Dishman Carbogen Amcis Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 59.32% | 59.32% | 59.32% | 59.32% |
| Mutual Funds | 1.28% | 2.17% | 3.45% | 3.28% |
| Foreign Portfolio Investors | 8.05% | 8.7% | 8.6% | 8.8% |
| Individual Investors | 27.09% | 25.17% | 24.53% | 24.64% |
| Others | 4.26% | 4.64% | 4.1% | 3.96% |
Dishman Carbogen Amcis Management
| Name | Designation |
|---|---|
| Mr. Janmejay R Vyas | Chairman |
| Mr. Arpit J Vyas | Global Managing Director |
| Mrs. Deohooti J Vyas | Whole Time Director |
| Mr. Sanjay S Majmudar | Independent Director |
| Mr. Ashok C Gandhi | Independent Director |
| Mr. Rajendra S Shah | Independent Director |
| Mr. Subir Kumar Das | Independent Director |
| Mr. Maitri K Mehta | Director |
Dishman Carbogen Amcis Forecast
Price Estimates
Dishman Carbogen Amcis Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-13 | Quarterly Results | |
| 2024-05-30 | Audited Results | |
| 2024-02-14 | Quarterly Results | |
| 2023-11-08 | Quarterly Results | |
| 2023-08-09 | Quarterly Results |
Dishman Carbogen Amcis FAQs
What is Share Price of Dishman Carbogen Amcis ?
Dishman Carbogen Amcis share price is ₹200 As on 18 September, 2024 | 02:25
What is the Market Cap of Dishman Carbogen Amcis ?
The Market Cap of Dishman Carbogen Amcis is ₹3149.5 Cr As on 18 September, 2024 | 02:25
What is the P/E ratio of Dishman Carbogen Amcis ?
The P/E ratio of Dishman Carbogen Amcis is -12.7 As on 18 September, 2024 | 02:25
What is the PB ratio of Dishman Carbogen Amcis ?
The PB ratio of Dishman Carbogen Amcis is 0.6 As on 18 September, 2024 | 02:25